Cumberland Pharmaceuticals Inc. Deferred Compensation Liability, Current and Noncurrent
Cumberland Pharmaceuticals Inc. (CPIX) had Deferred Compensation Liability, Current and Noncurrent of $3.40 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredCompensationLiabilityCurrentAndNoncurrent · last filed 2026-03-09
- 2025-12-31: Deferred Compensation Liability, Current and Noncurrent $3.40M.
- 2024-12-31: Deferred Compensation Liability, Current and Noncurrent $3.20M.
- 2023-12-31: Deferred Compensation Liability, Current and Noncurrent $2.90M.
- 2022-12-31: Deferred Compensation Liability, Current and Noncurrent $2.50M.
| Period end | Deferred Compensation Liability, Current and Noncurrent |
|---|---|
| 2025-12-31 | $3.40M 10-K · filed 2026-03-09 |
| 2024-12-31 | $3.20M 10-K · filed 2026-03-09 |
| 2023-12-31 | $2.90M 10-K · filed 2025-03-07 |
| 2022-12-31 | $2.50M 10-K · filed 2024-03-13 |
| 2021-12-31 | $3.40M 10-K · filed 2023-03-13 |
| 2020-12-31 | $2.70M 10-K · filed 2022-03-11 |
| 2019-12-31 | $2.30M 10-K · filed 2021-03-12 |
| 2018-12-31 | $1.60M 10-K · filed 2019-03-12 |
| 2017-12-31 | $1.60M 8-K · filed 2020-12-10 |
| 2016-12-31 | $1.20M 10-K · filed 2018-03-09 |
| 2015-12-31 | $700.00K 10-K · filed 2017-03-13 |
| 2014-12-31 | $600.00K 10-K · filed 2016-03-14 |
| 2013-12-31 | $300.00K 10-K · filed 2015-03-09 |
| 2012-12-31 | $100.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |